Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 61 - 70 of 245 for gsk. (0.07 seconds)

Gains six percent on Truvada's 88% efficacy. More details...
Advisory panel issues warning regarding antidepressants...
- Vioxx is the latest in a series of blockbusters or...
For the past week and a half the news hasn t been good,...
Financially and scientifically, Theravance is in bed with...
Vioxx puts another nail in the Blockbuster Drug Coffin....
Lots of Hype but Surrogate Marker Companies fizzle. More...
Can Vaccines Cure Cancer?. More details...
Some Good News, Some Not So Good. More details...
Dr. David Graham and the Dysfunctional FDA. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital